Latest news with #RM46.4m
Yahoo
30-05-2025
- Business
- Yahoo
Shin Yang Group Berhad Third Quarter 2025 Earnings: EPS: RM0.041 (vs RM0.031 in 3Q 2024)
Revenue: RM440.4m (up 75% from 3Q 2024). Net income: RM46.4m (up 34% from 3Q 2024). Profit margin: 11% (down from 14% in 3Q 2024). The decrease in margin was driven by higher expenses. EPS: RM0.041 (up from RM0.031 in 3Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Shin Yang Group Berhad shares are up 6.7% from a week ago. While earnings are important, another area to consider is the balance sheet. See our latest analysis on Shin Yang Group Berhad's balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données
Yahoo
21-03-2025
- Business
- Yahoo
Jaycorp Berhad Second Quarter 2025 Earnings: EPS: RM0.013 (vs RM0.02 in 2Q 2024)
Revenue: RM46.4m (down 20% from 2Q 2024). Net income: RM3.56m (down 33% from 2Q 2024). Profit margin: 7.7% (down from 9.1% in 2Q 2024). The decrease in margin was driven by lower revenue. EPS: RM0.013 (down from RM0.02 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Jaycorp Berhad shares are down 11% from a week ago. Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Jaycorp Berhad (1 shouldn't be ignored) you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
